The Impact of Pazopanib on the Cardiovascular System
Journal of Cardiovascular Pharmacology and Therapeutics · 2018-09 · 23 (5) · 387-398
DOI: 10.1177/1074248418769612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 29.04.2018. Verfasst von Cody N Justice und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Pazopanib is an approved treatment for renal cell carcinoma and a second-line treatment for nonadipocytic soft-tissue sarcoma. However, its clinical efficacy is limited by its cardiovascular side effects. Pazopanib and other vascular endothelial growth factor receptor tyrosine kinase inhibitors have been associated with the development of hypertension, QT interval prolongation, and other cardiovascular events; however, these mechanisms are largely unknown. Gaining a deeper understanding of these mechanisms is essential for the development of appropriate surveillance strategies and possible diagnostic biomarkers to allow us to monitor patients and modulate therapy prior to significant cardiac insult. This approach will be vital in keeping patients on these life-saving therapies and may be applicable to other tyrosine kinase inhibitors as well. In this review, we provide a comprehensive overview of the preclinical and clinical side effects of pazopanib with a focus on the mechanisms responsible for its toxicity to the cardiovascular system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA.
- 2 Mayo Clinic Scottsdale, Arizona, Phoenix, AZ, USA.
- 3 Division of Cardiology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA.
ORCID-Profile: Cody N Justice
Förderung
- NHLBI NIH HHS
Zitieren
APA
Justice, C. N., Derbala, M. H., Baich, T. M., Kempton, A. N., Guo, A. S., Ho, T. H., & Smith, S. A. (2018). The Impact of Pazopanib on the Cardiovascular System. Journal of Cardiovascular Pharmacology and Therapeutics, 23(5), 387-398. https://doi.org/10.1177/1074248418769612
Vancouver
Justice CN, Derbala MH, Baich TM, Kempton AN, Guo AS, Ho TH, et al. The Impact of Pazopanib on the Cardiovascular System. Journal of Cardiovascular Pharmacology and Therapeutics. 2018;23(5):387-398. doi:10.1177/1074248418769612
BibTeX
@article{Justice2018,
author = {Justice, Cody N and Derbala, Mohamed H and Baich, Tesla M and Kempton, Amber N and Guo, Aaron S and Ho, Thai H and Smith, Sakima A},
title = {The Impact of Pazopanib on the Cardiovascular System},
journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
year = {2018},
volume = {23},
number = {5},
pages = {387--398},
doi = {10.1177/1074248418769612}
}
EUVIMED